Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 08:44 am Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Panacea Innovation Ltd | 4,200,000 6.2% | 4,200,000 (New Position) | View |
| 2024-02-14 4:36 pm Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | PERCEPTIVE ADVISORS LLC | 1,869,125 2.8% | -4,219,208 (-69.30%) | View |
| 2024-02-14 10:24 am Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 2,962,555 4.4% | -1,672,051 (-36.08%) | View |
| 2024-02-14 07:15 am Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Point72 Asset Management L.P. | 3,202,381 4.7% | -268,310 (-7.73%) | View |
| 2024-02-13 4:58 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VANGUARD GROUP INC | 5,275,566 7.81% | 917,074 (+21.04%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | BlackRock Inc. BLK | 4,002,334 5.9% | 385,408 (+10.66%) | View |
| 2023-12-11 4:15 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Point72 Asset Management L.P. | 3,470,691 5.1% | 3,470,691 (New Position) | View |
| 2023-10-04 4:19 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 2,313,227 3.43% | -2,305,619 (-49.92%) | View |
| 2023-08-17 5:15 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 4,618,846 6.86% | -4,000,000 (-46.41%) | View |
| 2023-06-09 3:54 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | GOLDMAN SACHS GROUP INC GS | 3,653,782 5.4% | 3,653,782 (New Position) | View |
| 2023-04-03 4:43 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 8,618,846 12.92% | -683,296 (-7.35%) | View |
| 2023-02-14 2:33 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | PERCEPTIVE ADVISORS LLC | 6,088,333 9.2% | 3,116,920 (+104.90%) | View |
| 2023-02-14 1:18 pm Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 4,634,606 7% | -1,135,930 (-19.68%) | View |
| 2023-02-13 2:27 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | BlackRock Inc. BLK | 3,616,926 5.5% | 3,616,926 (New Position) | View |
| 2023-02-09 11:07 am Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VANGUARD GROUP INC | 4,358,492 6.58% | 4,358,492 (New Position) | View |
| 2022-09-30 4:05 pm Sale | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 9,302,142 15.89% | -1,376,666 (-12.89%) | View |
| 2022-09-21 4:16 pm Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | MILLENNIUM MANAGEMENT LLC | 1,621,025 2.8% | 1,621,025 (New Position) | View |
| 2022-09-09 9:50 pm Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 5,770,536 9.9% | -1,400,000 (-19.52%) | View |
| 2022-06-21 09:07 am Purchase | 13G | AMYLYX PHARMACEUTICALS INC AMLX | PERCEPTIVE ADVISORS LLC | 2,971,413 5.1% | 2,971,413 (New Position) | View |
| 2022-01-25 4:54 pm Purchase | 13D | AMYLYX PHARMACEUTICALS INC AMLX | Morningside Venture Investments Ltd | 10,678,808 18.9% | 10,678,808 (New Position) | View |